Gupta Ashoo
SEC insider (Form 3/4/5 filer). CIK 0002091461. VP, Finance and Controller at 4D Molecular Therapeutics, Inc. (FDMT). 8 reported Form 4/5 transactions since Sep 2024; latest on Mar 20, 2026. Located in EMERYVILLE, CA.
Companies Gupta Ashoo has filed insider reports for
- 4D Molecular Therapeutics, Inc. (FDMT): Officer, VP, Finance and Controller
Gupta Ashoo
CIK: 0002091461
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
4D Molecular Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Mar 20, 2026FDMT
4D Molecular Therapeutics, Inc.
SaleDirect80 shares at avg. $8.61$688.8 - Mar 20, 2026FDMT
4D Molecular Therapeutics, Inc.
ExerciseDirect865 shares- - Mar 20, 2026FDMT
4D Molecular Therapeutics, Inc.
SaleDirect310 shares at avg. $8.61$3K - Mar 20, 2026FDMT
4D Molecular Therapeutics, Inc.
ExerciseDirect221 shares- - Dec 20, 2025FDMT
4D Molecular Therapeutics, Inc.
ExerciseDirect866 shares- - Dec 20, 2025FDMT
4D Molecular Therapeutics, Inc.
SaleDirect310 shares at avg. $8.68$3K - Dec 20, 2025FDMT
4D Molecular Therapeutics, Inc.
ExerciseDirect220 shares- - Dec 20, 2025FDMT
4D Molecular Therapeutics, Inc.
SaleDirect79 shares at avg. $8.68$685.72
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 20, 2026 | FDMT 4D Molecular Therapeutics, Inc. | Sale | 80 | $8.61 | $689 | Direct |
| Mar 20, 2026 | FDMT 4D Molecular Therapeutics, Inc. | Exercise | 865 | - | $0 | Direct |
| Mar 20, 2026 | FDMT 4D Molecular Therapeutics, Inc. | Sale | 310 | $8.61 | $2,669 | Direct |
| Mar 20, 2026 | FDMT 4D Molecular Therapeutics, Inc. | Exercise | 221 | - | $0 | Direct |
| Dec 20, 2025 | FDMT 4D Molecular Therapeutics, Inc. | Exercise | 866 | - | - | Direct |
| Dec 20, 2025 | FDMT 4D Molecular Therapeutics, Inc. | Sale | 310 | $8.68 | $2,691 | Direct |
| Dec 20, 2025 | FDMT 4D Molecular Therapeutics, Inc. | Exercise | 220 | - | - | Direct |
| Dec 20, 2025 | FDMT 4D Molecular Therapeutics, Inc. | Sale | 79 | $8.68 | $686 | Direct |
1-8 of 8 transactions